GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.73
-0.10 (-0.78%)
At close: Jun 13, 2025, 4:00 PM
12.76
+0.03 (0.24%)
After-hours: Jun 13, 2025, 4:04 PM EDT
GH Research Employees
GH Research had 50 employees as of December 31, 2024. The number of employees increased by 1 or 2.04% compared to the previous year.
Employees
50
Change (1Y)
1
Growth (1Y)
2.04%
Revenue / Employee
n/a
Profits / Employee
-$842,140
Market Cap
791.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
GHRS News
- 4 weeks ago - GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - GlobeNewsWire
- 5 weeks ago - GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - GH Research Announces Pricing of $150 Million Public Offering - GlobeNewsWire
- 4 months ago - GH Research Announces Proposed Public Offering - GlobeNewsWire
- 4 months ago - Why Is GH Research Stock Trading Higher On Monday? - Benzinga
- 4 months ago - GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction - GlobeNewsWire
- 4 months ago - GH Research to Provide Update on Phase 2b Trial with GH001 in TRD - GlobeNewsWire